Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

RTTNews | vor 773 Tagen
Stocktwits
Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

(RTTNews) - Lavie Bio Ltd., a subsidiary of ag-biologicals company Evogene Ltd. (EVGN) announced on Monday a licensing agreement with ag innovation company Corteva Inc. (CTVA), that grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.

The agreement comes after two years of independent field validation conducted by both companies.

The agreement is part of Lavie Bio's strategy to cooperate with the world's leading companies to allow the products it develops to reach farmers worldwide and Corteva, with its proven agbiological capabilities, can leverage Lavie Bio's product candidates toward commercial success.

This collaboration demonstrates both companies' commitment to providing farmers with environmentally friendly, sustainable tools with proven effectiveness.

Tags: EVGN CTVA
Stocktwits
read more
Corteva Sees Q3 Results Below Estimates; Slashes FY23 Outlook

Corteva Sees Q3 Results Below Estimates; Slashes FY23 Outlook

Announcing preliminary net sales and earnings results for the third quarter on Friday, Corteva, Inc. (CTVA) now expects third-quarter loss from continuing operations of $0.45 per share on net sales of approximately $2.6 billion.
RTTNews | vor 671 Tagen
Lavie Bio Appoints Guri Oron As CEO

Lavie Bio Appoints Guri Oron As CEO

Lavie Bio Ltd., a subsidiary of Evogene Ltd. (EVGN), announced Wednesday the appointment of Guri Oron as Chief Executive Officer of Lavie Bio, effective as of September 18, 2022.
RTTNews | vor 1079 Tagen
Japan Data On Tap For Friday

Japan Data On Tap For Friday

Japan is scheduled to release a batch of data on Friday, headlining a busy day for Asia-Pacific economic activity. On tap are July figures for unemployment, industrial production, retail sales, housing starts and construction orders, as well as August data for household confidence and Tokyo inflation.
RTTNews | vor 12 Minuten
Euro Climbs Against Majors

Euro Climbs Against Majors

The euro firmed against its major counterparts in the New York session on Thursday.
RTTNews | vor 43 Minuten
Swiss Market Ends Marginally Up

Swiss Market Ends Marginally Up

The Switzerland market ended marginally up on Thursday after a choppy ride as stocks swung between gains and losses right through the day's trading session.
RTTNews | vor 4Std 21 Minuten
European Stocks Close Weak

European Stocks Close Weak

European stocks closed lower on Thursday as the mood remained largely cautious with investors closely following geopolitical news, digesting tech giant Nvidia's earnings, and some crucial economic data from the U.S.
RTTNews | vor 4Std 41 Minuten
Tools
Wirtschaftskalender
Handelszeiten
Zinssätze
Feiertagskalender
Forex-Markt
Forex-Volatilität
Forex-Korrelation
Forex-Nachrichten
Forex-Analyse
COT-Daten
Liquidität
Forex-Rechner
Forex Heatmap
Konjunkturindikatoren
Community
Community
Systeme
Beliebteste Systeme
Strategien
Wettbewerbe
Forex-Charts
Forex-Sentiment
Prognoseindikator
Bewertungen
Broker
Proprietäre Handelsfirmen
VPS-Dienste
Signalanbieter
EA Programmierdienstleistungen
Affiliate-Programme
PAMM - Broker-Dienstleistungen
Rabattprogramm-Dienstleistungen
Handelsplattformen
Expertenberater
Krypto-Börsen
Trading kurse
Broker
Forex-Spreads
Forex-Broker-Kotierungen
Forex-Broker-Swaps
Volumen des Forex-Brokers
Forex-Broker-Aktionen
Pressemitteilung
Plattform
Widgets
Funktionen
API
RSS
Stock Portfolio
Affiliate Software
Erweiterte Charts
Betreuung
FAQ
Hilfe
Kontaktieren Sie uns
Fehler melden!
Über uns
Blog
© 2025 Myfxbook Ltd. Alle Rechte vorbehalten.
WARNUNG VOR HOHEM RISIKO: Der Devisenhandel birgt ein hohes Risiko, das möglicherweise nicht für alle Anleger geeignet ist. Der Einsatz von Leverage schafft zusätzliches Risiko und Verlustgefahr. Bevor Sie sich für den Devisenhandel entscheiden, sollten Sie Ihre Anlageziele, Ihr Erfahrungsniveau und Ihre Risikotoleranz sorgfältig prüfen. Sie könnten Ihre ursprüngliche Investition teilweise oder ganz verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren. Informieren Sie sich über die mit dem Devisenhandel verbundenen Risiken und lassen Sie sich von einem unabhängigen Finanz- oder Steuerberater beraten, wenn Sie Fragen haben. Alle Daten und Informationen werden ausschließlich zu Informationszwecken bereitgestellt und sind nicht für Handelszwecke oder Beratung gedacht. Die vergangene Performance ist kein Indikator für zukünftige Ergebnisse.